Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Total Liabilities (2014 - 2026)

Updated

Evofem Biosciences' Total Liabilities came in at $95.04 million for Q2 2026, up 13.1% from $84 million a year earlier and up 11.7% from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Total Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Evofem Biosciences' Total Liabilities was $94.61 million, down 0.5% from FY2024.

  • Total Liabilities carries a five-year compound annual growth rate of -2.7% (FY2020 to FY2025).
  • Going back by year, Total Liabilities was $95.05 million in FY2024 (+23.3%), $77.06 million in FY2023 (-20.5%), $96.96 million in FY2022 (-34.0%) and $146.83 million in FY2021 (+35.2%).
  • The Q2 2026 figure represents the highest quarterly Total Liabilities since Q4 2024.
  • Year-over-year, Total Liabilities increased in six of the last eight quarters, with growth averaging 10.2%.
  • The fastest year-over-year change in Total Liabilities over five years came in Q2 2022 (growth of 170.1%), and the weakest in Q2 2023 (a decline of 74.1%).
  • Business Quant data shows EVFM's Total Liabilities at $85.07 million (Q1 2026), $94.61 million (Q4 2025) and $88.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 116.09 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 141.05 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 65.46 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn 37.53 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 115.64 Bn
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn 95.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.04 Mn
Mar 31, 2026 85.07 Mn
Dec 31, 2025 94.61 Mn
Sep 30, 2025 88.87 Mn
Jun 30, 2025 84.00 Mn
Mar 31, 2025 82.46 Mn
Dec 31, 2024 95.05 Mn
Sep 30, 2024 94.83 Mn
Jun 30, 2024 77.87 Mn
Mar 31, 2024 78.88 Mn
Dec 31, 2023 77.06 Mn
Sep 30, 2023 69.68 Mn
Jun 30, 2023 69.74 Mn
Mar 31, 2023 82.44 Mn
Dec 31, 2022 96.96 Mn
Sep 30, 2022 120.33 Mn
Jun 30, 2022 269.47 Mn
Mar 31, 2022 162.67 Mn
Dec 31, 2021 146.83 Mn
Sep 30, 2021 126.25 Mn
API Access

Evofem Biosciences Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=EVFM&period=max&api_key=YOUR_API_KEY